China National Medicines Corporation Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 22,001.19 million compared to CNY 22,064 million a year ago. Revenue was CNY 22,006.49 million compared to CNY 22,075.75 million a year ago.

Net income was CNY 862.25 million compared to CNY 765.85 million a year ago. Basic earnings per share from continuing operations was CNY 1.1428 compared to CNY 1.015 a year ago. Diluted earnings per share from continuing operations was CNY 1.1428 compared to CNY 1.015 a year ago.